Zacks Investment Research Upgrades Medical Properties Trust (MPW) to Hold

Zacks Investment Research upgraded shares of Medical Properties Trust (NYSE:MPW) from a sell rating to a hold rating in a report issued on Wednesday morning.

According to Zacks, “Medical Properties Trust, Inc. is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT’s financing model allows hospitals and other healthcare facilities to unlock the value of their underlying real estate in order to fund facility improvements, technology upgrades, staff additions and new construction. Facilities include acute care hospitals, inpatient rehabilitation hospitals, long-term acute care hospitals, and other medical and surgical facilities. “

Several other brokerages have also recently issued reports on MPW. Stifel Nicolaus set a $14.00 price target on shares of Medical Properties Trust and gave the company a hold rating in a research report on Thursday, November 1st. Mitsubishi UFJ Financial Group upped their price target on shares of Medical Properties Trust to $15.00 and gave the company a neutral rating in a research report on Friday, November 2nd. JMP Securities set a $16.00 price target on shares of Medical Properties Trust and gave the company a buy rating in a research report on Monday, October 1st. Finally, Jefferies Financial Group cut shares of Medical Properties Trust from a buy rating to a hold rating and set a $15.00 price target for the company. in a research report on Tuesday, July 17th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the company. Medical Properties Trust presently has an average rating of Hold and a consensus target price of $14.19.

NYSE MPW traded down $0.14 on Wednesday, hitting $16.60. The company’s stock had a trading volume of 201,673 shares, compared to its average volume of 2,815,072. The company has a debt-to-equity ratio of 0.90, a quick ratio of 2.19 and a current ratio of 4.92. Medical Properties Trust has a 1-year low of $11.82 and a 1-year high of $16.74. The stock has a market cap of $5.96 billion, a P/E ratio of 12.30, a price-to-earnings-growth ratio of 3.46 and a beta of 0.47.

Medical Properties Trust (NYSE:MPW) last announced its quarterly earnings results on Thursday, November 1st. The real estate investment trust reported $0.35 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.34 by $0.01. Medical Properties Trust had a net margin of 124.88% and a return on equity of 9.06%. The firm had revenue of $197.00 million during the quarter, compared to analysts’ expectations of $192.64 million. During the same period in the prior year, the company posted $0.33 EPS. The company’s revenue was up 11.6% on a year-over-year basis. Analysts predict that Medical Properties Trust will post 1.37 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 11th. Stockholders of record on Thursday, September 13th were given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 6.02%. The ex-dividend date of this dividend was Wednesday, September 12th. Medical Properties Trust’s dividend payout ratio (DPR) is presently 74.07%.

In other news, Director Michael G. Stewart sold 12,400 shares of the stock in a transaction on Friday, October 12th. The shares were sold at an average price of $14.13, for a total transaction of $175,212.00. Following the completion of the sale, the director now directly owns 231,039 shares in the company, valued at $3,264,581.07. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Emmett E. Mclean sold 100,000 shares of the stock in a transaction on Wednesday, August 22nd. The stock was sold at an average price of $14.93, for a total transaction of $1,493,000.00. Following the sale, the insider now owns 963,965 shares of the company’s stock, valued at $14,391,997.45. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 127,400 shares of company stock valued at $1,890,812. 0.83% of the stock is currently owned by corporate insiders.

Institutional investors and hedge funds have recently bought and sold shares of the company. Bay Colony Advisory Group Inc d b a Bay Colony Advisors acquired a new stake in shares of Medical Properties Trust during the second quarter worth $104,000. Cornerstone Wealth Management LLC bought a new position in Medical Properties Trust during the second quarter worth $583,000. Valeo Financial Advisors LLC bought a new position in Medical Properties Trust during the second quarter worth $128,000. Integrated Investment Consultants LLC bought a new position in Medical Properties Trust during the second quarter worth $136,000. Finally, Investors Asset Management of Georgia Inc. GA ADV bought a new position in Medical Properties Trust during the second quarter worth $140,000. Institutional investors own 77.17% of the company’s stock.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Read More: What does the Dow Jones Industrial Average (DJIA) measure?

Get a free copy of the Zacks research report on Medical Properties Trust (MPW)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply